Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
05/27/2009 | CN100490832C Method for preparing kidney-warming face-nourishing liquor containing micron pine pollen, deer placenta powder, glossy privet fruit powder, white fungus, safflower etc. |
05/27/2009 | CN100490677C Nutritious tablet for female |
05/26/2009 | US7538121 Vanilloid receptor modulators |
05/26/2009 | US7538118 6-aminomorphinane derivatives, method for production and use thereof |
05/26/2009 | US7538100 17α-alkyl-17β-oxy-estratrienes and intermediate products for their production, use of the 17α-alkyl-17β-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations |
05/26/2009 | US7538099 Antiprogestin method and kit for reducing side effects associated with low dosage HRT, oral contraception and regulating menses |
05/26/2009 | US7537887 Relates to regulation of activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity; methods of screening for agonists or antagonists of NET in order to identify new pro- or anti-angiogenic compounds |
05/26/2009 | CA2463264C 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
05/26/2009 | CA2454675C 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents |
05/26/2009 | CA2436668C Novel succinate salt of o-desmethyl-venlafaxine |
05/26/2009 | CA2387201C Tetrahydroquinoline derivatives |
05/26/2009 | CA2295512C Prostaglandin product |
05/26/2009 | CA2242879C Method for treating sexual dysfunctions |
05/22/2009 | WO2009063993A1 Fused pyridine derivative and use thereof |
05/22/2009 | WO2009063991A1 Pyridooxazepine derivative and use thereof |
05/22/2009 | WO2009063365A1 Azetidines as ep2 antagonists |
05/22/2009 | WO2009062910A1 Composition for moderating triglyceride and cholesterol levels |
05/22/2009 | WO2009062683A1 C-19 steroids for therapeutic uses |
05/22/2009 | WO2009062402A1 Quinazolinone derivatives, the preparation methods and uses thereof |
05/22/2009 | WO2009062338A1 A lactogenic chinese medicine for treatment and prevention of gynecopathy, methods of preparation and uses thereof |
05/22/2009 | CA2705368A1 Azetidines as ep2 antagonists |
05/21/2009 | US20090131465 Synthesis and crystalline forms of melanocortin-4 receptor agonist |
05/21/2009 | US20090131404 Combinations |
05/21/2009 | US20090131387 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
05/21/2009 | US20090130126 Dna expression vectors |
05/20/2009 | EP2060621A1 Wheat-germ oil concentrate, a method for the production thereof, a method for producing wheat-germ oil and a medicinal and prophylactic composition based thereon and used for treating sexual dysfunctions |
05/20/2009 | EP2060300A1 C-19 steroids for therapeutic uses |
05/20/2009 | EP2059802A2 Methods for designing parp inhibitors and uses thereof |
05/20/2009 | EP2059248A1 Pharmaceutical preparation for the alleviation of endometriosis |
05/20/2009 | EP1888058B1 Inhibitors of soluble adenylate cyclase |
05/20/2009 | EP1365760B1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
05/20/2009 | EP1208113B1 17beta-acyl-alpha-propynyl-11beta-(cyclic amino)aryl steroids and their derivatives having antagonist hormonal properties |
05/20/2009 | CN101434575A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
05/20/2009 | CN101434574A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
05/20/2009 | CN101434573A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
05/20/2009 | CN101433724A Use of Akt2-siRNA fusion expression vector in preparing medicament for inhibiting metastasis of human breast cancer cell |
05/20/2009 | CN101433714A Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation |
05/20/2009 | CN101433706A Method for preparing decoction for invigorating spleen |
05/20/2009 | CN101433700A Medicament for treating climacteric syndrome and preparation method thereof |
05/20/2009 | CN101433668A Prescription of wine for beauty treatment and face nursing and production method |
05/20/2009 | CN101433656A Vaginitis treating medicine |
05/20/2009 | CN101433654A Chinese medicine preparation for treating women's chronic pelvic inflammatory disease and preparation method thereof |
05/20/2009 | CN101433650A Chinese medicinal composition for treating intermenstrual flow and dysmenorrhea |
05/20/2009 | CN101433623A Capsule for health preserving of female and nursing face and preparation method thereof |
05/20/2009 | CN101433611A Method for making wine for strengthening force |
05/20/2009 | CN101433602A Process for preparing wine for mainly treating intolerance of cold, anemia and gynecopathy |
05/20/2009 | CN101433585A Use of pharmaceutical composition in preparing medicament for preventing and treating gynaecologic disease |
05/20/2009 | CN101433568A Extraction of burdock root aqueous extract and use |
05/20/2009 | CN100488525C Medicine for treating female climacterium syndrome and its preparation method |
05/20/2009 | CN100488517C Composition for trapping and inactivating pathogenic microbes and spermatozoa and its pharmaceutical uses |
05/20/2009 | CN100488510C Morpholine derivatives for use as dopamine agonists in the treatment of I.A. sexual dysfunction |
05/20/2009 | CN100488509C Sildenafil citrate sublingual tablet and its preparation method |
05/19/2009 | US7534790 Aminocyclohexyl ether compounds such as trans-[2-(4-morpholinyl)-1-(2-naphthenethoxy)]cyclohexane; arrhythmia, analgesia and local anesthesia |
05/19/2009 | US7534441 Immunogenic LHRH compositions and methods relating thereto |
05/19/2009 | CA2382580C Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders |
05/19/2009 | CA2230931C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
05/14/2009 | WO2009062034A1 Methods, compositions, and sequences of zp-binding peptides for immunocontraception of dogs and other animals |
05/14/2009 | WO2009060609A1 Method for producing microcapsule using solid fat |
05/14/2009 | WO2009059961A2 A method of hormone suppression in humans |
05/14/2009 | WO2009059765A2 Process for the preparation of drospirenone |
05/14/2009 | WO2009059690A1 Use of a gestagen in combination with an estrogen and one or more pharmaceutically tolerable excipients/carriers for lactose-free oral contraceptive |
05/14/2009 | WO2009042127A3 Compositions and methods for rescuing fertility |
05/14/2009 | WO2009016350A3 Stimulating gel |
05/14/2009 | WO2008041236A3 Composition comprising crustacean gastrolith components, calcium carbonate and its use |
05/14/2009 | US20090124590 Pharmaceutical composition |
05/14/2009 | US20090124589 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
05/14/2009 | US20090124541 Method for the recovery and application of novel human defensins as biologically active proteins for the treatment of infections and other diseases |
05/14/2009 | US20090124537 Screening method for bone morphogenetic mimetics |
05/14/2009 | US20090123571 Method of treating men with testosterone supplement and 5alpha-reductase inhibitor |
05/14/2009 | US20090123534 comprising progesterone, soy bean lecithin, and olive oil, wherein at least about 80% of the particles of progesterone are characterized by a particle size of between 1 and 15 mu m; for treating a physiological condition linked to insufficiency of progesterone secretion |
05/14/2009 | US20090123522 Medicament Delivery Device and a Method of Medicament Delivery |
05/14/2009 | US20090123503 Conditioned Cell Culture Medium Compositions and Methods of Use |
05/14/2009 | US20090123433 Compositions Comprising Human Embryonic Stem Cells and their Derivatives, Methods of Use, and Methods of Preparation |
05/14/2009 | CA2704523A1 Use of a gestagen in combination with an estrogen and one or more pharmaceutically tolerable excipients/carriers for lactose-free oral contraceptive |
05/14/2009 | CA2703497A1 A method of hormone suppression in humans |
05/13/2009 | EP2058310A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor comprising the derivative |
05/13/2009 | EP2058305A1 Urea derivative |
05/13/2009 | EP2057905A1 Composition for moderating Triglyceride and Cholesterol Levels |
05/13/2009 | EP1655028B1 Use of cyclic bioisosteres of purine system derivatives for the treatment of diseases caused by disorders of nitrergic and dopaminergic systems |
05/13/2009 | CN101429166A Quinazoline ketone derivant, preparation method and application thereof |
05/13/2009 | CN101428140A Sustained-release incretion particle for inducing maturation of Oplegnathus fasciatus gonad and preparation method thereof |
05/13/2009 | CN101428139A Method for extending spermiation period of verasper moseri |
05/13/2009 | CN101428106A Medicament composition for treating female acyesis and aphoria, and uses thereof |
05/13/2009 | CN101428041A Cordyceps sinensis extract, preparation method and uses in preparing medicament |
05/13/2009 | CN101427993A Prostaglandin microemulsion gel rubber preparation and method of producing the same |
05/13/2009 | CN101427983A Female washing and protecting condensation with sterilizing effect and method of producing the same |
05/13/2009 | CN100486995C Compositions and methods for WT1 specific immunotherapy |
05/13/2009 | CN100486967C 5HT2C receptor modulators |
05/13/2009 | CN100486618C Medicine for treating gynecologic menstrual irregularities and difficult menstruation and production thereof |
05/13/2009 | CN100486581C Progesterone membrane agent and its preparing method |
05/13/2009 | CN100486576C Substituted pyridinones as modulators of P38MAP kinase |
05/13/2009 | CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use |
05/13/2009 | CN100486570C Use of luciferin and derivatives in preparing medicine for treating live animal secretory diarrhea and inhibiting cyst growth |
05/13/2009 | CN100486471C Magnetic beads activity factor cream massage bra |
05/13/2009 | CN100486426C Method for constructing allotetraploid of bluntsnout bream |
05/12/2009 | US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation |
05/12/2009 | US7531635 Monoclonal antibodies or functional fragment; immunoassay kit; female fertility diagnosis; Premature ovarian failure |
05/12/2009 | US7531625 Nucleotide sequences coding neuronal outgrowth and stability protein for use in treating ovarian, renal, neurological, cell proliferative and cardiovascular disorders |
05/12/2009 | US7531571 4-benzyl-2-phenylchroman skeleton with hydroxyl substitutions compounds; estrogen beta -receptors (ER beta ) modulator; hormone replacement therapy; osteoporosis, postmenopause; side effect reduction |
05/12/2009 | US7531564 Substituted benzoxazoles as estrogenic agents |